Announced Tue, 21 Jul · 19:43 IST
MedPlus Q1 FY27: revenue up 22 percent, margins decline
MEDPLUS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
-9.5%1-day move
₹791.00
prior close
₹719.10
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-5.9-6.4-6.5-7.5-9.5-8.7-9.0———————
Up moveDown movePending
AI summary
Revenue grew 21.8% YoY to Rs 18,796 million in Q1 FY27. Gross margin fell 160 bps to 24.5% on lower private label mix and weaker franchisee margins. Operating EBITDA dropped to Rs 651 million (margin 3.5% versus 4.7%). PAT fell 21.7% to Rs 332 million. Added 146 stores, network at 5,476. Diagnostics revenue up 22%. Met 99% of revenue plan but only 82% of EBITDA target.
Likely market impact
Mixed results: strong revenue and store expansion, but margins and profits declined. EBITDA missed internal targets.